Last reviewed · How we verify
Toronto association
Toronto association drug is used to treat various conditions by modulating the immune system.
Toronto association drug is used to treat various conditions by modulating the immune system. Used for Various conditions.
At a glance
| Generic name | Toronto association |
|---|---|
| Sponsor | EMS |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Toronto association drug works by modulating the immune system, which helps to treat various conditions. However, the exact mechanism of action is not well understood.
Approved indications
- Various conditions
Common side effects
- Unknown
Key clinical trials
- A-B-C Program for Sedentary Older Adults With Depressive Symptoms (NA)
- Investigation of Ultrasonographic Measurements of Lower Extremity Nerves in Type 2 Diabetes Patients With Peripheral Polyneuropathy
- Cortical Inhibition in Patients With Multiple Sclerosis
- RCT of MBCT vs HEP for Late-Life Depression (NA)
- Relationship of Point-of-care Coagulation Assays with Clinical Outcomes in Cardiac Surgery: a Retrospective Cohort Study
- Effect of a Rent Subsidy and Mentoring on Youth Transitioning Out of Homelessness (NA)
- Optimizing Mental Health for Infants Exposed to Early Adversity: A Comparison of Breaking the Cycle and Maxxine Wright (NA)
- Childhood Trauma in Schizophrenia: Exploration of Links Between Gene Expression, Cerebral Morphology and Symptomatology
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Toronto association CI brief — competitive landscape report
- Toronto association updates RSS · CI watch RSS
- EMS portfolio CI